Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Homecoming Closes $4 Million Seed Funding Round To Scale Psychedelic Therapy Companion Tools


News provided by

Homecoming

Apr 07, 2022, 07:00 ET

Share this article

Share toX

Share this article

Share toX

Homecoming's psychedelic therapy companion platform
Homecoming's psychedelic therapy companion platform

Homecoming helps psychedelic clinics and retreats optimize outcomes for patients

TORONTO, April 7, 2022 /PRNewswire-PRWeb/ -- Homecoming, the creator of industry-leading patient engagement tools for psychedelic therapy, announced today that it has closed an over-subscribed $4 million seed funding round. The company will use the funding to scale its products and services, enabling clinics and retreats to effectively streamline their operations, improve patient care, and deliver better outcomes.

Investors in the seed round included Evolve Ventures and Integrated, who led the round, along with SV Angel, Bridge Builders Collaborative, Amanda Feilding, Lionheart Ventures, Ocama LP, JLS Fund, Michael Cotton, Seth Feuerstein, Talia Eisenberg, Jesse Hudson, and David Fraga.

Through its industry-leading commitments to equity, reciprocity, and community, Homecoming is modeling how businesses can consciously support giving back while scaling transformative technologies.

Post this

"On our mission to combine best in class product design and community reciprocity commitments, we cannot be happier with the combination of mission-alignment and expertise among the investors in this round," says Homecoming founder Yuriy Blokhin. "With their financial and strategic support, we are positioned to become the backbone infrastructure for the emerging field of psychedelic-assisted psychotherapy, and ensure that our growth is fully aligned with the success of all stakeholders in the ecosystem."

The Homecoming platform went live in October 2021, giving practitioners a powerful new way to support psychedelic therapy. With thoughtfully designed experiences and tools to help guide patients through each stage of treatment—before, between, and after sessions—Homecoming supports clients even before they arrive at a clinic or retreat, and after they graduate from a program. The platform is built on research showing that psychedelic therapy patients can achieve better outcomes when they prepare ahead of sessions, and continuously work to integrate their experiences afterward.

"Homecoming is setting the gold standard for psychedelic therapy technology platforms by providing better patient care and adherence, streamlining operations for clinic staff, and improving financial outcomes for clinic owners," says Julius Mokrauer, Managing Director of Evolve Ventures. "It is providing an essential service for scaling up not just individual clinics, but the entire field of psychedelic treatments for mental health."

"Homecoming's contribution to psychedelic therapy and the field at large goes well beyond its intentional, patient-centric design," says Andrew Chomer, General Partner at Integrated. "Through its industry-leading commitments to equity, reciprocity, and community, Homecoming is modeling how businesses can consciously support giving back while scaling transformative technologies."

After notching a successful seed round, Homecoming is expanding its service to new clinics and retreats in addition to diversifying its product offering within its existing set of clients.

"We at Nushama aim to humanize medicine, and our collaboration with Homecoming is allowing us to do just that," said Richard Meloff, co-founder of Nushama, a network of psychedelic wellness clinics that uses Homecoming. "Homecoming offers a platform where members have access to key preparation materials which provide not just information, but guidance and support from the beginning. Homecoming allows us to implement our protocols beyond the treatment setting, helping our members feel supported throughout their journey with us and beyond. They receive platform updates for community events, promoting connection, as well as reminders to breathe and check in with themselves, promoting self-care. With this mission-aligned partnership, we can create a level of support for our community that surpasses anything we could do alone. We are better together."

Homecoming is also investing in developing new, more engaging resources and exercises for tech-augmented preparation and integration. Homecoming is in the process of creating a customizable program for ketamine therapy content, developed by leading ketamine therapists and clinical psychologists. The company also plans to use the seed funding to bring on talented new members of its fast-growing team.

With psychedelic therapy poised to revolutionize healthcare, Homecoming founder and CEO Yuriy Blokhin launched the company in 2021 on a mission to give back to the community while amplifying the work of psychedelic clinics. Ten percent of Homecoming's entire equity pool has been directed to its non-profit partners: The Beckley Foundation, Therapsil, ICEERS, MAPS Canada, Canadian Psychedelic Association, Sage Institute, Reconsider, and the Heroic Hearts Project, a nonprofit that Blokhin co-founded to provide educational, financial, and counseling options to military veterans with PTSD seeking access to ayahuasca.

The app is now available for iPhone and Android as well as there's available a modern web application for healthcare providers. Membership is required to access its features. Clinicians can sign up by scheduling a demo or contacting Homecoming at [email protected].

About Homecoming

Homecoming is a patient care platform for psychedelic therapy that partners with psychedelic clinics, therapists, and retreats to support clients before, between, and after sessions. Homecoming supports healing journeys with personalized guides, tasks, and daily check-ins, as well as preparation and integration support through a single, user-friendly platform for clinics. Homecoming helps clinics reach more patients and fulfill operational goals using modern therapy tools, precision data, and enhanced management of the entire patient experience.

About Evolve Ventures

Evolve Ventures is a $100 million early-stage venture fund focused on impact. With a presence in the San Francisco Bay Area, New York, and Shanghai, Evolve supports conscious, mission-driven visionaries who use technology to create platforms, applications, and initiatives focused on alleviating inner suffering and facilitating personal transformation. While they prioritize impact over profit, they believe that in the coming decade, many important and profitable companies will be created to address the world's growing mental health challenges and to facilitate the evolution of human consciousness. Other recent investments include Insight Timer, Parent Lab, Fabriq, and 10% Happier.

About Integrated

Integrated is a venture fund partnering with value-aligned companies transforming the health and wellbeing of our communities around the globe. Our intention is to support early stage organizations focused on redefining healthcare through the advancement of medicines and the integration of transformational therapies. Our partners work includes research and development, diverse therapeutic delivery methods, and innovative wellness technologies.

Media Contact

Brad Burge, Homecoming, 1 6508636887, [email protected]

SOURCE Homecoming

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.